Dilip Shanghvi

Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more

In this article, we will take a look at Shanghvi’s journey, family, education, net worth and more.

April 29, 2023 09:00 IST

Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab

The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in active-comparator etanercept arm

Updated: May 4, 2016 17:52 IST

RIL’s Mukesh Ambani, Wipro’s Azim Premji, Sun’s Dilip Shanghvi in top 50 wealthiest people list: Wealth-X

Reliance Industries Mukesh Ambani, Wipro chief Azim Premji and Sun Pharmaceutical Industries’ Dilip Shanghvi, have made it to a global…

January 28, 2016 16:24 IST

Mukesh Ambani, Azim Premji, Dilip Shanghvi among world’s 50 wealthiest

The list of top 50 wealthiest people in the world have a combined fortune of $1.45 trillion, nearly equal to…

January 28, 2016 13:14 IST

‘DRILS Synergy 2015’ symposium organised

The programme saw industry leaders and academia under one roof to discuss opportunities to build a culture of innovation and…

Updated: August 31, 2015 18:20 IST

Sun Pharma posts net profit of Rs 479 crores Q1FY16

Net sales has been registered at Rs 6,522 crores Sun Pharmaceutical Industries has posted its financials for first quarter ending…

August 12, 2015 09:28 IST

Indian billionaires: Gautam Adani, Dilip Shangvhi see highest growth

Gautam Adani, 52, has added nearly $3 billion (Rs 19,000 crore) to his wealth on soaring shares of his companies.

Updated: May 31, 2015 07:54 IST

SAC-ACCP organises eighth annual international conference

Felicitates six industry stakeholders and institutions South Asian Chapter of American College of Clinical Pharmacology (SAC-ACCP) recently organised its eighth…

April 24, 2015 17:09 IST

Suzlon Energy snaps 2 day losing streak as open offer from Dilip Shanghvi begins

Shares of Suzlon Energy snapped two-day losing streak on Wednesday after Dilip Shanghvi Family and Associates…

Updated: April 16, 2015 02:11 IST

Sun Pharma announces closure of merger deal with Ranbaxy

The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations

Updated: March 25, 2015 17:23 IST

CCI approves Ranbaxy acquisition by Sun Pharma

Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with…

December 9, 2014 10:32 IST

Related News

Watchlist 2026: 3 super investor stocks trading at a 40%+ discount,

Damani, Jhunjhunwala & Nemish Shah: 3 ‘deep value’ picks down 40-80%

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

India's maritime MRO revolution: Aatmanirbhar Bharat's next frontier for shipping giants. (Image Source: Mazagondock)

Stop chasing shipbuilding. The real story is ship repair: 3 stocks to watch

Avatar: Fire and Ash on track for explosive debut, posing major challenge to Dhurandhar

Life40 min ago

“Avatar: Fire and Ash, the third installment in the Avatar series, is releasing on December 19 and is expected to dominate the Indian Box Office. With over 1.3 million interests on BookMyShow and high ticket prices, the film is predicted to make over Rs 500 crore. This could pose a threat to Dhurandhar, which has already earned Rs 180 crore, as it may face competition from the Na’vi.

View all shorts